[Research progress on mTOR signaling pathway and regulatory T cell nutrition metabolic regulation mechanism]

Ming Wu1, Fang Wang2

  • 1Department of Laboratory Medicine, First Affiliated Hospital of Nanjing Medical University, Nanjing 210029; Department of Clinical Laboratory, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai 201102, China.

Insights

The mammalian target of rapamycin (mTOR) pathway regulates T cell metabolism in tumors, impacting immune suppression and tumor escape. Targeting mTOR offers potential for cancer immunotherapy, despite current challenges.

Area of Science:

  • Immunology
  • Metabolic pathways
  • Cancer research

Background:

  • Metabolic reprogramming in the tumor microenvironment influences T cell function, promoting immunosuppression and tumor immune escape.
  • The mammalian target of rapamycin (mTOR) signaling pathway is crucial for regulating immune cell functions.
  • Understanding mTOR's role in T cell metabolism is key to overcoming tumor-induced immunosuppression.

Approach:

  • This review elucidates the molecular mechanisms by which mTOR signaling regulates cellular energy metabolism.
  • It examines mTOR activation under various nutritional conditions.
  • The review synthesizes current research on mTOR signaling in regulatory T cell (Treg) metabolism and function.

Key Points:

  • mTOR signaling critically controls T cell metabolic reprogramming within the tumor microenvironment.
  • Nutritional status significantly affects mTOR pathway activation and subsequent T cell function.
  • mTOR plays a vital role in the metabolism and immunosuppressive functions of regulatory T cells (Tregs).

Conclusions:

  • The mTOR pathway is a significant regulator of T cell metabolism and immune responses in cancer.
  • mTOR presents a promising target for clinical immunotherapeutic strategies against tumors.
  • Challenges remain in the clinical application of mTOR-targeted therapies, requiring further investigation.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.9K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K